Isentress Tablet, Chewable
Product Images NDC 0006-0473

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Isentress (NDC 0006-0473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isentress 01)

Chemical structure of the active ingredient Raltegravir from ISENTRESS tablets. The diagram shows the molecular arrangement including multiple rings, carbon, nitrogen, oxygen atoms, and a potassium ion (K+).*

FDA Label Image

Figure (Isentress 02)

Illustration showing three sleeping infants in different positions: on the side with hands near the face, curled with arms crossed, and lying with hands near the cheeks, all depicted with varying skin tones and minimal clothing.*

FDA Label Image

Figure (Isentress 03)

Packaging label of ISENTRESS 100 mg chewable tablets by Merck Sharp & Dohme LLC. The box is white with black text and features branding and product concentration information on the sides visible in the image. The label indicates it is an oral tablet formulation.*

FDA Label Image

Figure (Isentress 04)

An illustration showing two open containers intended for oral use, each with a single tablet inside. The containers are transparent with lids removed, depicting the chewable tablet dosage form for ISENTRESS (RALTEGRAVIR).*

FDA Label Image

Figure (Isentress 05)

FDA Label Image

Figure (Isentress 06)

ISENTRESS chewable tablets packaging showing four flip-top boxes. Each box label includes the proprietary name ISENTRESS, the generic name Raltegravir, and clear space for printing lot and expiry information. The image displays the product as orally administered chewable tablets from Merck Sharp & Dohme LLC. Exact strengths are not legible on the packages shown.*

FDA Label Image

Figure (Isentress 07)

An illustration showing two blue oral syringes with clear graduated markings and adjustable plungers, likely used for administering medication doses.*

FDA Label Image

Figure (Isentress 08)

FDA Label Image

Figure (Isentress 09)

Illustration of two oral dosing syringes with measurement markings. The image likely relates to the administration of ISENTRESS (raltegravir) chewable tablets, showing dosing tools for oral delivery.*

FDA Label Image

Figure (Isentress 10)

An instructional illustration showing a container with a hinged lid being opened, indicated by a pink arrow pointing upward and backward. The image demonstrates how to open the container lid for accessing the contents.*

FDA Label Image

Figure (Isentress 11)

ISENTRESS 100 mg chewable tablets packaging label shows a barcode with Lot number, Expiration date, and Ded code fields. The label is primarily black and white without additional visible text or design elements.*

FDA Label Image

Figure (Isentress 12)

An illustration of a simple empty cup or glass, depicted as a transparent cylindrical container with an open top and a closed circular base, shown in a line drawing style.*

FDA Label Image

Figure (Isentress 13)

An instructional diagram showing three types of oral syringes in various sizes and colors, likely to illustrate correct dosing or administration techniques. The syringes are graduated and colored blue, green, and white, with measurement markings visible on each.*

FDA Label Image

Figure (Isentress 14)

An instructional illustration showing a hand filling a glass with water from a faucet, positioned next to an image of a closed water bottle. The images are separated by the word "OR," indicating two options for obtaining water.*

FDA Label Image

Figure (Isentress 15)

An instructional diagram of an oral syringe showing the labeled parts: tip, syringe barrel with volume markings in milliliters, and the plunger highlighted in blue with a pink arrow indicating the direction of plunger movement to dispense medication. The syringe is designed for accurate oral liquid dosing.*

FDA Label Image

Figure (Isentress 16)

An instructional illustration showing a hand holding a syringe-like applicator submerged in a cup of water with an upward arrow indicating the movement to pull the plunger, likely demonstrating how to prepare a dose by mixing or drawing liquid orally.*

FDA Label Image

Figure (Isentress 17)

An instructional illustration showing a hand holding a syringe with liquid at the 2 mL mark. The image highlights a close-up view of the syringe barrel marked at 1, 2, and 3 mL, noting the presence of air bubbles that need attention. The other hand appears to be flicking the syringe to remove these air bubbles.*

FDA Label Image

Figure (Isentress 18)

An instructional illustration showing a person holding a syringe-like measuring device filled to the 10 mL level with liquid. An inset magnifies the measurement markings, highlighting the 10 mL line. An upward arrow indicates the fluid being pushed or expelled from the device.*

FDA Label Image

Figure (Isentress 19)

An instructional diagram showing a hand holding a small container with a flip-top lid being opened, while the other hand is inserting a syringe or dropper into the container. A pink arrow emphasizes the action of opening the lid.*

FDA Label Image

Figure (Isentress 20)

An instructional diagram showing a hand holding and shaking a small packet with perforation lines, suggesting the packet should be torn open with scissors prior to use.*

FDA Label Image

Figure (Isentress 21)

An instructional illustration showing hands opening a foil packet and pouring its contents into a cup, demonstrating preparation or administration steps likely related to the product ISENTRESS chewable tablets.*

FDA Label Image

Figure (Isentress 22)

An instructional illustration showing a hand shaking a small container horizontally, with red arrows indicating the shaking motion around the container. A stopwatch icon displays "45 SECONDS," suggesting the container should be shaken for 45 seconds.*

FDA Label Image

Figure (Isentress 23)

An instructional illustration showing a human profile looking at a transparent container with a flip-top lid. The image appears to demonstrate visual inspection of the container's contents or usability.*

FDA Label Image

Figure (Isentress 24)

An instructional diagram showing the dosage box of ISENTRESS chewable tablets by Merck Sharp & Dohme LLC. The illustration points to a blank area on the box where the child's dose is indicated, demonstrating where personalized dosing information will be written on the packaging.*

FDA Label Image

Figure (Isentress 25)

An instructional illustration showing an oral syringe with measurement markings from 1 mL downward. A close-up inset highlights the plunger tip with a red arrow and text instructing to move the plunger to the right mark on the syringe, indicating precise dosing adjustment.*

FDA Label Image

Figure (Isentress 26)

An illustration of a green liquid measurement device marked in milliliters, displaying volume increments from 0.5 mL to 3 mL. The device has a tapered top and bottom, resembling a dosing syringe or medicine dropper, used for precise oral dosing.*

FDA Label Image

Figure (Isentress 27)

An illustration of a cylindrical oral syringe with measurement markings from 1 mL to 10 mL in 1 mL increments, used for accurate liquid drug dosing.*

FDA Label Image

Figure (Isentress 28)

An instructional diagram of an oral syringe showing the labeled parts: the barrel and the plunger. The plunger is indicated by a pink arrow. This image serves to identify components of the syringe used for oral medication administration.*

FDA Label Image

Figure (Isentress 29)

Instructional illustration showing hands using a dropper, drawing liquid from a small container with a screw-on cap. An upward arrow indicates pulling the dropper out of the container.*

FDA Label Image

Figure (Isentress 30)

An instructional illustration showing a hand holding a syringe with volume measurements marked from 1 mL to 3 mL and the presence of air bubbles indicated. Another hand is positioned near the syringe, likely to tap or expel the air bubbles. The diagram focuses on proper syringe preparation or usage technique.*

FDA Label Image

Figure (Isentress 31)

An instructional illustration showing a person holding a syringe vertically at eye level, aligning their sight with the syringe's measurement marks while pushing the plunger. This image likely demonstrates how to properly read the volume of liquid in a syringe.*

FDA Label Image

Figure (Isentress 32)

Illustration showing an adult hand administering oral medication to an infant using an oral syringe aimed into the infant's mouth. The image demonstrates proper technique for oral dosing in a pediatric patient.*

FDA Label Image

Figure (Isentress 33)

An instructional illustration depicting a hand rinsing a small container and medical syringes under running water from a faucet. The image suggests cleaning medical equipment, such as syringes and a vial, likely related to proper hygiene or disposal procedures for medication.*

FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Label for Isentress (raltegravir) tablets, 400 mg strength. The label indicates 60 chewable tablets per bottle, with each tablet containing 434.4 mg raltegravir potassium equivalent to 400 mg raltegravir. The product is distributed by Merck Sharp & Dohme LLC and includes storage instructions and a depiction of a single brown tablet embossed with '227'.*

FDA Label Image

Principal Display Panel (600 mg Bottle Label)

Label for ISENTRESS HD (raltegravir) tablets 600 mg, chewable oral tablets. The package contains 60 tablets and is labeled for prescription use only. The label includes dosage information, stating two tablets once daily, and identifies the product as manufactured by Merck Sharp & Dohme LLC. The label also displays an image of a single oblong tablet imprinted with '242.'*

FDA Label Image

Principal Display Panel (100 mg Bottle Label)

Isentress (raltegravir) 100 mg chewable tablets label for oral use by Merck Sharp & Dohme LLC. The label indicates a pediatric oral dosage form, with 60 tablets per package. It includes a warning for phenylketonurics about phenylalanine content. The image shows an embossed tan tablet marked with '477'.*

FDA Label Image

Principal Display Panel (25 mg Bottle Label)

Label for Isentress (raltegravir) chewable tablets, 25 mg strength, manufactured by Merck Sharp & Dohme LLC. The label indicates a package size of 60 tablets and includes usage notes such as pediatric use and phenylketonurics warning. It features dosage form as chewable tablets and highlights the Rx only designation, with distribution and manufacturing information. The label includes barcodes and a tablet imprint of '473'.*

FDA Label Image

Principal Display Panel (100 mg Packet Carton)

Packaging label for Isentress (raltegravir) oral suspension 100 mg, a pediatric multi-dose kit. The label indicates the product is for oral administration only and contains 60 packets per kit. The kit includes mixing cups and syringes of various sizes. Labeler is Merck Sharp & Dohme LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.